Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-06
1998-12-22
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 534 14, 514 54, 53612312, A61K 5100, A61M 3614
Patent
active
058515097
ABSTRACT:
This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents, methods and kits for making the agents, and methods for using the agents to image pathological sites, including sites of infection, inflammation, cancer and atherosclerosis in a mammalian body. Specifically the agents and reagents are derivatives of oligosaccharides, more specifically .beta.-glucans.
REFERENCES:
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4431626 (1984-02-01), Henze
patent: 5057503 (1991-10-01), Czop et al.
patent: 5208324 (1993-05-01), Klareness et al.
patent: 5336762 (1994-08-01), Ranney
patent: 5368840 (1994-11-01), Unger
patent: 5422095 (1995-06-01), Hasiguchi et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5561220 (1996-10-01), Dean et al.
patent: 5582172 (1996-12-01), Papisov et al.
patent: 5607677 (1997-03-01), Jamas et al.
Zubay, Biochemistry, 1983, pp. 438-446.
Vorne et al., 1989, "Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: Comparison with gallium-67 citrate," J. Nucl. Med. 30: 1332-1336.
Czop, 1986, "The role of .beta.-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation," Pathol. Immunopathol. 5: 286-296.
Czop and Austen, 1985, "A .beta.-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway," J. Immunol. 134: 2588-2593.
Ebright et al., 1982, "The gallium scan: Problems and misuse in examination of patients with suspected infection," Arch. Int. Med. 142: 246-254.
Bartnicki-Garcia, 1968, "Cell wall chemistry, morphogenesis and taxonomy of fungi," Ann. Rev. Microbiol. 22: 87-108.
Zubay, 1983, Biochemistry, pp. 438-446.
Manners et al., 1974, "The Heterogeneity of Glucan Preparations from the Walls of Various Yeasts," J. Gen. Microbiol. 80: 411-417.
Her et al., 1987, "Simplified Approach to HPLC Precolumn Fluorescent Labeling of Carbohydrates: N-(2-Pyridinyl)-Glycosylamines," J. Carbohydrate Chemistry 6: 129-139.
Bogwald et al., 1986, "Coupling of Polysaccharides Activated by Means of Chloroacetaldehyde Dimethyl Acetal to Amines or Proteins by Reductive Amination," Carbohydrate Research 148: 101-107.
Smedsrod et al., "Fate of Intravenously Injected Aminated Beta(1-3)Polyglucose Derivatized with 125I-Tyraminyl Cellobiose," Immunopharmacology 21(3): 149-158 (1991).
Rasmussen et al., "Dynamics of Blood Components and Peritoneal Fluid During Treatment of Murine E. Coli Sepsis With Beta-1, 3-Polyglucose Derivatives," Scandinavian Journal of Immunology, 32(4):321-331 (1990).
Diatide, Inc.
Hollinden Gary E.
Jones Dameron
McDaniels Patricia A.
Noonan Kevin E.
LandOfFree
Radiolabeled glucans covalently linked to a radiolabel binding m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled glucans covalently linked to a radiolabel binding m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled glucans covalently linked to a radiolabel binding m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2043253